CRISPR

A new study from an international team of geneticists is suggesting we are further away than many realize from being able to effectively genetically select for complex polygenic traits such as IQ or height and create designer babies.

Promising data from one of the first human trials testing a CRISPR gene therapy has just been revealed. Although it is too early to evaluate long-term effects, the initial reports demonstrate success for two patients with genetic blood diseases.

CRISPR is a powerful gene-editing tool – but it has its own problems too. Now, Harvard and MIT scientists have created a new approach called prime editing, which could correct almost 90 percent of disease-causing genes.

Humanity is poised to take a huge leap forward, as a convergence of next-gen technologies combine to give us unprecedented power over our own biology. Here's a roadmap to the key technologies and how it's going to play out in the coming decades.

One of the most promising types of cancer treatment involves boosting the immune system’s response to the presence of cancer, and now two new mouse studies out of Yale University are reporting breakthroughs in this area.

Researchers at Griffith University in Australia have used the CRISPR-Cas9 gene-editing system to effectively cure cervical cancer in mice.

Scientists have used the CRISPR gene-editing tool to give fruit flies a new evolutionary advantage – the ability to eat poison and store it in their bodies.

In lab tests, researchers have identified a cellular “switch” that could be turned off to clear out HIV lying dormant inside cells.

The CRISPR tool is often referred to as “genetic scissors,” but a new improvement turns it into a “genetic Swiss Army Knife.”

Researchers have managed to successfully edit the genes of lizards with CRISPR for the first time, turning them albino.

New MIT and Harvard research shows how versatile CRISPR is, putting the genetic scissors to work in diagnostic tools and timed drug delivery systems.

An incredible new breakthrough from scientists at ETH Zurich has, for the first time, demonstrated a new CRISPR method that can modify dozens of genes simultaneously, allowing for more large-scale cell reprogramming.